Literature DB >> 7960998

Performance status after treatment for squamous cell cancer of the base of tongue--a comparison of primary radiation therapy versus primary surgery.

L B Harrison1, M J Zelefsky, J G Armstrong, E Carper, J J Gaynor, R B Sessions.   

Abstract

PURPOSE: To compare the quality of life and functional outcome in patients with squamous cell cancer of the base of tongue treated with primary radiation vs. primary surgery. METHODS AND MATERIALS: At our institution, patients with base of tongue cancer are primarily treated either by radiation or surgery depending upon the philosophy of their primary physician. Primary radiation consists of 45-54 Gy external beam radiation followed by an 192Ir implant delivering an additional 20-30 Gy over 2-3 days. A neck dissection is done at the same time as the implant for those with involved nodes. Primary surgery consists of resection of the base of tongue lesion, neck dissection and postoperative radiation therapy. Because both groups have similar local control in our experience (80-90%), we used a subjective performance status scale for head and neck cancer patients to assess the quality of life in these patients (0-100, 0 = worst function, 100 = normal function). This scale measures ability to eat in public, understandability of speech, and normalcy of diet. There were 30 radiation patients (21: T1-T2; nine: T3-T4) and ten surgery patients (five: T1-T2; five: T3-T4) available for long-term quality of life assessment.
RESULTS: Patients treated with radiation had consistently better performance status scores and quality of life according to our study. This was true for those with early (T1-2) as well as more advanced (T3-4) disease. For eating in public, T1-2 patients had scores of 85 vs. 75 (p = .31) and T3-4 patients had scores of 82 vs. 35 (p < .0001) for radiation vs. surgery, respectively. For understandability of speech, T1-2 patients had scores of 92 vs. 65 (p = .0021), and T3-4 patients had scores of 95 vs. 35 (p < .0001) for radiation vs. surgery, respectively. For normalcy of diet, T1-2 patients had scores of 74 vs. 50 (p = .047), and T3-4 patients had scores of 78 vs. 32 (p = .0012) for radiation vs. surgery, respectively. In addition, we compared scores for early vs. advanced disease treated by the same modality. For radiation, there was no difference in all three functional categories for T1-2 vs. T3-4 (p = .84), showing that quality of life scores remain high for all stages. For surgery, functional status deteriorated significantly when comparing T1-2 vs. T3-4 (p = .0014), consistent with the fact that larger tumors require more extensive operations.
CONCLUSION: Radiation therapy provides a better performance status than surgery for base of tongue cancer. This is true for both early and advanced disease. Because radiation also provides similar local control and survival, our data suggests that radiation may be the preferred strategy. Functional scores remain high for all T stages treated with radiation, but deteriorate with more advanced T stages for patients treated with surgery. Similar studies using objective criteria are needed to further compare these treatments.

Entities:  

Mesh:

Year:  1994        PMID: 7960998     DOI: 10.1016/0360-3016(94)90371-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Treatment of oral cancer. Radiotherapy may be as effective as surgery.

Authors:  I Kunkler
Journal:  BMJ       Date:  1999-09-11

2.  Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

Authors:  M A List; P Mumby; D Haraf; A Siston; R Mick; E MacCracken; E Vokes
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

3.  The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.

Authors:  H J Aarstad; A K H Aarstad; S Lybak; O Monge; D F Haugen; J Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-05       Impact factor: 2.503

Review 4.  Controversies in the management of tongue base cancer.

Authors:  J P O'Neill; J P Hughes; K P Manning; J E Fenton
Journal:  Ir J Med Sci       Date:  2008-09-23       Impact factor: 1.568

5.  Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment.

Authors:  C L Lazarus; H Husaini; K Hu; B Culliney; Z Li; M Urken; A Jacobson; M Persky; T Tran; C Concert; D Palacios; R Metcalfe-Klaw; M Kumar; B Bennett; L Harrison
Journal:  Dysphagia       Date:  2014-03-08       Impact factor: 3.438

6.  [Brachytherapy for the treatment of head and neck cancer].

Authors:  J E Meyer; C Brocks; S Maune; V Strnad; J A Werner; B Wollenberg; G Kovács
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

7.  Validity of a dysphagia screening test following resection for head and neck cancer.

Authors:  Nobuhide Horii; Yoko Hasegawa; Ayumi Sakuramoto-Sadakane; Shyota Saito; Tomoki Nanto; Yuta Nakao; Kazuhisa Domen; Takahiro Ono; Hiromitsu Kishimoto
Journal:  Ir J Med Sci       Date:  2020-06-30       Impact factor: 1.568

8.  Intensity modulated radiotherapy (IMRT) in the management of locally advanced oropharyngeal squamous cell carcinomata (SCC): disease control and functional outcome using the therapy outcome measure (TOM) score--report from a single U.K. institution.

Authors:  Charlotte J Ingle; Kent Yip; Valerie Caskie; Catherine Dyson; Amanda Ford; Christopher D Scrase
Journal:  Head Neck Oncol       Date:  2010-10-14

Review 9.  Biological staging of head and neck cancer and its role in developing effective treatment strategies.

Authors:  W M Lydiatt; S P Schantz
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Recent advances in image-guided radiotherapy for head and neck carcinoma.

Authors:  Sameer K Nath; Daniel R Simpson; Brent S Rose; Ajay P Sandhu
Journal:  J Oncol       Date:  2009-07-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.